Skip to main content
The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · IEX Real-Time Price · USD
0.526
+0.004 (0.71%)
Jul 26, 2024, 4:30 PM EDT - Market closed

The Oncology Institute Revenue

The Oncology Institute had revenue of $94.67M in the quarter ending March 31, 2024, with 24.25% growth. This brings the company's revenue in the last twelve months to $342.71M, up 25.30% year-over-year. In the year 2023, The Oncology Institute had annual revenue of $324.24M with 28.42% growth.

Revenue (ttm)
$342.71M
Revenue Growth
+25.30%
P/S Ratio
0.11
Revenue / Employee
$428,391
Employees
800
Market Cap
39.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023324.24M71.76M28.42%
Dec 31, 2022252.48M49.48M24.37%
Dec 31, 2021203.00M15.49M8.26%
Dec 31, 2020187.52M32.11M20.66%
Dec 31, 2019155.41M42.25M37.33%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeueHealth 1.11B
Nortech Systems 138.66M
Qilian International Holding Group 46.47M
Aligos Therapeutics 13.79M
Dyadic International 2.26M
BioXcel Therapeutics 1.76M
OncoCyte 1.38M
Envoy Medical 297.00K
Revenue Rankings

TOI News

More News